Hyman Charles D Has $4.83 Million Position in Colgate-Palmolive (NYSE:CL)

Hyman Charles D decreased its position in Colgate-Palmolive (NYSE:CL) by 0.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 60,570 shares of the company’s stock after selling 500 shares during the period. Hyman Charles D’s holdings in Colgate-Palmolive were worth $4,828,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. OFI Invest Asset Management acquired a new position in shares of Colgate-Palmolive in the third quarter valued at approximately $25,000. Avion Wealth boosted its stake in Colgate-Palmolive by 78.1% in the 4th quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after purchasing an additional 175 shares during the period. McGlone Suttner Wealth Management Inc. bought a new position in Colgate-Palmolive during the 4th quarter worth about $34,000. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of Colgate-Palmolive by 142.0% in the 3rd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after purchasing an additional 291 shares during the period. Finally, West Branch Capital LLC lifted its holdings in shares of Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock valued at $54,000 after purchasing an additional 132 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CL shares. Evercore ISI lifted their target price on Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a research report on Monday, April 8th. Raymond James raised shares of Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research report on Monday, January 29th. Morgan Stanley upped their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the stock an “overweight” rating in a report on Monday, January 29th. Citigroup increased their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Finally, Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research report on Monday, April 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus target price of $91.44.

Colgate-Palmolive Price Performance

NYSE:CL traded up $0.90 during trading hours on Tuesday, reaching $94.08. 3,987,097 shares of the company were exchanged, compared to its average volume of 4,665,950. The business has a 50 day moving average of $88.64 and a 200 day moving average of $82.63. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $94.21. The company has a debt-to-equity ratio of 13.21, a current ratio of 1.06 and a quick ratio of 0.70. The company has a market capitalization of $77.19 billion, a P/E ratio of 29.77, a P/E/G ratio of 3.43 and a beta of 0.40.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.04. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.96 billion. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. Colgate-Palmolive’s quarterly revenue was up 6.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.73 EPS. Research analysts forecast that Colgate-Palmolive will post 3.52 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a dividend of $0.50 per share. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.13%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Insider Activity at Colgate-Palmolive

In related news, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at approximately $22,797,983.85. The sale was disclosed in a filing with the SEC, which is available through this link. In related news, insider Jennifer Daniels sold 3,538 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the sale, the insider now owns 59,698 shares in the company, valued at approximately $5,054,629.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of Colgate-Palmolive stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold 159,048 shares of company stock valued at $13,336,846 over the last three months. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.